CAMBRIDGE NEUROSCIENCE INC
10-Q, EX-27.1, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: CAMBRIDGE NEUROSCIENCE INC, 10-Q, 2000-08-14
Next: AMERICAN MEDICAL TECHNOLOGIES INC/DE, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FORM 10Q 6/30/00
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FORM 10Q
</LEGEND>
<CIK> 0000874384
<NAME> CAMBRIDGE NEUROSCIENCE INC.
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                           2,614
<SECURITIES>                                     5,981
<RECEIVABLES>                                       30
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 9,351
<PP&E>                                             233
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   9,584
<CURRENT-LIABILITIES>                            1,470
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            18
<OTHER-SE>                                       8,096
<TOTAL-LIABILITY-AND-EQUITY>                     9,584
<SALES>                                              0
<TOTAL-REVENUES>                                   645
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 2,830
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (1,913)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (1,913)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,913)
<EPS-BASIC>                                     (0.11)
<EPS-DILUTED>                                   (0.11)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission